| Literature DB >> 33737424 |
Nexhmedin Morina1, Ahlke Kip2, Thole Hilko Hoppen2, Stefan Priebe3, Thomas Meyer2.
Abstract
BACKGROUND: The imperative for physical distancing (mostly referred to as social distancing) during COVID-19 pandemic may deteriorate physical and mental health. We aimed at summarising the strength of evidence in the published literature on the association of physical and mental health with social connection via social isolation, living alone and loneliness.Entities:
Keywords: health & safety; health policy; mental health; public health; risk management
Mesh:
Year: 2021 PMID: 33737424 PMCID: PMC7978290 DOI: 10.1136/bmjopen-2020-042335
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flow diagram of study selection process.
Overview of the included meta-analyses
| Publication | Social connection | Clinical outcome | Study design | Age: | Literature search: timespan | Range of follow- up | N databases searched | Quality score |
| Besora-Moreno | Living alone | Malnutrition/ | Cross-sectional | 60+ | 01.2000–12.2018 | n.a. | 2 | L |
| Results: | Living alone | Combined effect | ||||||
| Heidari Gorji | Living alone, social isolation, loneliness | Hospital readmission in patients with heart failure | Longitudinal | 70.87 (8.62) | Up to 11.2018 | 13 months | 6 | H |
| Results: | Any type of poor social connection | Combined effect | ||||||
| Living alone or social isolation | Combined effect | |||||||
| Loneliness | Combined effect | |||||||
| Holt-Lunstad | Living alone, social isolation, loneliness | Early mortality | Longitudinal | 66.00 (n.r.) | 01.1980–02.2014 | 7.1 years | 5 | L |
| Results: | Living alone | Unadjusted studies | ||||||
| Living alone | Studies with multiple covariates | |||||||
| Social isolation | Unadjusted studies | |||||||
| Social isolation | Studies with multiple covariates | |||||||
| Loneliness | Unadjusted studies | |||||||
| Loneliness | Studies with multiple covariates | |||||||
| Jain | Living alone | Reduced vaccine uptake in older adults | Cross-sectional*† | 60+ | Up to 02.2016 | n.r. | 2 | M |
| Results: | Living alone | Seasonal influenza vaccine | ||||||
| Living alone | Pneumococcal vaccine | |||||||
| Kojima | Living alone | Frailty in older adults | Cross-sectional† and longitudinal† | 60+ | 2000–02.2019 | n.r. | 1 | L |
| Results: | Living alone | Cross-sectional studies | ||||||
| Subanalysis: only men | ||||||||
| Subanalysis: only women | OR=1.00 (95% CI: 0.83 to 1.20); k=22; N=n .r. | |||||||
| Subanalysis:≥60,<70 years old | ||||||||
| Subanalysis:≥80 years old | OR=0.96 (95% CI: 0.69 to 1.31); k=6; N=n .r. | |||||||
| Living alone | Longitudinal studies | OR=0.88 (95% CI: 0.76 to 1.03); k=6; N=38 549 | ||||||
| Maes | Loneliness | Chronic physical conditions in children/adolescents | Cross-sectional* | Children<12 and adolescents<21 | 1987–06.2016 | n.r. | 4 | L |
| Results: | Loneliness | Combined effect (excluding three outliers) | ||||||
| Subanalysis: control group studies | ||||||||
| Subanalysis: hearing/visual problems | ||||||||
| Rico-Uribe | Loneliness | Early | Longitudinal† | Mainly 50+ | Up to 06.2016 | n.r. | 4 | H |
| Results: | Loneliness | Combined effect | ||||||
| Subanalysis: only men | ||||||||
| Subanalysis: only women | ||||||||
| Smith | Social isolation, loneliness | Inflammation | Cross-sectional* | 16+ | Up to 07.2019 | n.r. | 5 | H |
| Results: | Social isolation | C reactive protein: unadjusted studies | ||||||
| C reactive protein: adjusted studies | r=0.021 (95% CI:.051 to 0.092); k=11; N=41 911 | |||||||
| Fibrinogen: unadjusted studies | ||||||||
| Fibrinogen: adjusted studies | ||||||||
| Interleukin-6: unadjusted studies | r=0.267 (95% CI: −0.341 to 0.718); k=4; N=12 291 | |||||||
| Interleukin-6: adjusted studies | r=-.003 (95% CI: −0.148 to 0.141); k=6; N=14 243 | |||||||
| Loneliness | C reactive protein: unadjusted studies | r=0.047 (95% CI: −0.003 to 0.098); k=8; N=17 835 | ||||||
| C reactive protein: adjusted studies | r=0.023 (95% CI: −0.018 to 0.065); k=6; N=19 292 | |||||||
| Fibrinogen: unadjusted studies | r=0.006 (95% CI: −0.057 to 0.070); k=3; N=1806 | |||||||
| Fibrinogen: adjusted studies | r=0.037 (95% CI: −0.015 to 0.089); k=4; N=7672 | |||||||
| Interleukin-6: unadjusted studies | r=0.082 (95% CI: −0.001 to 0.163); k=4; N=4219 | |||||||
| Interleukin-6: adjusted studies | ||||||||
| Steptoe and Kivimäki | Social isolation, loneliness | Cardiovascular disease | Longitudinal† | n.r. | Up to 2011 | n.r. | n.r. | CL |
| Results: | Social isolation or | Combined effect | ||||||
| Valtorta | Social isolation, loneliness | Coronary heart disease and stroke | Longitudinal† | 18+ | Up to 05.2015 | 3 to 21 years | 16 | H |
| Results: | Social isolation or | Coronary heart disease | ||||||
| Social isolation | Stroke incidence | |||||||
| Chang | Living alone, loneliness | Late-life suicidal ideation | Cross-sectional*‡ | 50+ | 01.2000–11.2016 | n.r. | 7 | L |
| Results: | Living alone | Combined effect | ||||||
| Loneliness | Combined effect | |||||||
| Chatterjee | Social isolation, loneliness | Depression in civilians after 9/11 | Longitudinal | 43.78 (n.r.) | 09.2001–07.2016 | n.r. | 3 | L |
| Results: | Social isolation or loneliness | Combined effect | ||||||
| Chau | Loneliness | Psychosis | Cross-sectional*‡ | Adults (mainly) | Up 10.2018 | n.r. | 5 | M |
| Results: | Loneliness | Positive symptoms | ||||||
| Subanalysis: clinical populations | ||||||||
| Subanalysis: non-clinical populations | ||||||||
| Subanalysis: mixed populations | ||||||||
| Subanalysis: Paranoia | ||||||||
| Subanalysis: Hallucinations | ||||||||
| Loneliness | Negative psychotic symptoms | |||||||
| Subanalysis: clinical populations | ||||||||
| Subanalysis: non-clinical populations | ||||||||
| Subanalysis: mixed populations | ||||||||
| Choi and Smith | Social isolation | Adolescents’ smoking behaviours | Cross-sectional | <19 | n.r. | n.a. | 3 | CL |
| Results: | Social isolation | Network position: isolate vs member | ||||||
| Network position: isolated vs liaison | ||||||||
| Erzen and Çikrikci | Loneliness | Depression | Cross-sectional* | Adults | Up to 01.2018 | n.r. | 2 | CL |
| Results: | Loneliness | Combined effect | ||||||
| Subanalysis: clinical populations | ||||||||
| Subanalysis: other populations | ||||||||
| Evans | Social isolation | Cognitive functioning | Longitudinal | 50+ | Up to 01.2018 | 2–24 years | 4 | M |
| Results: | Social isolation | Combined effect | ||||||
| Subanalysis: global measures | ||||||||
| Subanalysis: memory | ||||||||
| Subanalysis: executive functioning | ||||||||
| Kuiper | Social isolation, loneliness | Risk of dementia | Longitudinal† | 60+ | Up to 07.2012 | 2 to 15 years | 3 | M |
| Results: | Social isolation | Low social network size | RR=1.17 (95% CI: 0.92 to 1.48); k=5; N=7749 | |||||
| Social isolation | Low level of participation | |||||||
| Social isolation | Low frequency of contacts | |||||||
| Loneliness | Feeling lonely | |||||||
| Loneliness | Low satisfaction with social network | RR=1.25 (95% CI: 0.96 to 1.62); k=4; N=6207 | ||||||
| Lara | Loneliness | Dementia and mild cognitive impairment | Longitudinal† | 50+ | Up to 11.2018 | n.r. | 6 | H |
| Results: | Loneliness | Combined effect | ||||||
| Maes | Loneliness | Social anxiety in children/adolescents | Cross-sectional and longitudinal | 15.59 (4.27) | 1981–06.2016 | 1.25 to 72 months | 4 | CL |
| Results: | Loneliness | Cross-sectional effects | ||||||
| Loneliness | Longitudinal/cross-lagged effects | |||||||
| Mahon | Loneliness | Depression and social anxiety in adolescence | Cross-sectional* | Adolescents (11–23) | 1980–2004 | n.r. | 4 | CL |
| Results: | Loneliness | Depression | ||||||
| Subanalysis: outliers removed | ||||||||
| Loneliness | Anxiety | |||||||
| Subanalysis: outliers removed | ||||||||
| Michalska da Rocha | Loneliness | Psychosis | Cross-sectional*‡ | Adults | Up to 02.2016 | n.r. | 4 | H |
| Results: | Loneliness | Combined effect | ||||||
| Penninkilampi | Living alone, social isolation, loneliness | Risk of dementia | Longitudinal and case-control | 60+ | 01.2012–05.2017 | 5.9 years | 8 | L |
| Results: | Any type of poor social connection | Combined effect | ||||||
| Social isolation | Combined effect | |||||||
| Living alone | Combined effect | |||||||
| Loneliness | Combined effect | RR=1.38 (95% CI: 0.98 to 1.94); k=4; N=4698 | ||||||
| Teo | Living alone | Social anxiety disorder | Cross-sectional* | Adults (mainly) | 01.1980–02.2011 | n.r. | 4 | M |
| Results: | Living alone | Combined effect | ||||||
| Subanalysis: large survey studies | ||||||||
| Xiu-Ying | Living alone | Late life depression | Cross-sectional and longitudinal | 55+ | 1966–08.2007 | n.r. | 3 | CL |
| Results: | Living alone | Cross-sectional effects | ||||||
| Subanalysis: versus living with family | ||||||||
| Living alone | Longitudinal/cross-lagged effects | RR=1.27 (95% CI: 0.89 to 1.80); k=4; N=1345 | ||||||
| Yuan | Living alone | Postacute coronary syndrome depression | Longitudinal and case-control | 19+ | 01.1996–03.2018 | n.r. | 4 | L |
| Results: | Living alone | Combined effect | ||||||
For each result, we specify the type of social connection, the focus of the (sub)analysis, followed by the reported effect size (in brackets: CIs), as well as included numbers of independent studies and participants. Most meta-analyses included studies both with adjusted and unadjusted effect sizes (typically controlling for potential confounders like age, sex, education, socioeconomic status, chronic conditions, depression or anxiety). Unless specified in the table, the authors did not indicate a preference for adjusted or for unadjusted effect sizes. Note that adequate consideration of confounding is also in part reflected in the quality scores. Effect sizes printed in boldface are statistically significant at alpha=0.05.
*These studies included different study designs and extracted cross-sectional data or aggregated longitudinal and cross-sectional data.
†Effect sizes with adjustment for confounders were preferred in this meta-analysis.
‡Effect sizes with no or minimal adjustment were preferred in this meta-analysis.
CL, critically low; H, high; L, low; M, moderate; n.a., not applicable; n.r., not reported.